Radiomics of Liver Metastases: A Systematic Review


Statistical learning
Radiomics of Liver Metastases: A Systematic Review
Friday 16th October 2020
Fiz, F.; Viganò, L.; Gennaro, N.; Costa, G.; La Bella, L.; Boichuk A.; Cavinato, L.; Sollini, M.; Politi, L. S.; Chiti, A.; Torzilli, G.
Download link:
Patients with liver metastases can be scheduled for different therapies (e.g., chemotherapy, surgery, radiotherapy, and ablation). The choice of the most appropriate treatment should rely on adequate understanding of tumor biology and prediction of survival, but reliable biomarkers are lacking. Radiomics is an innovative approach to medical imaging: it identifies invisible-to-the-human-eye radiological patterns that can predict tumor aggressiveness and patients outcome. We reviewed the available literature to elucidate the role of radiomics in patients with liver metastases. Thirty-two papers were analyzed, mostly (56%) concerning metastases from colorectal cancer. Even if available studies are still preliminary, radiomics provided effective prediction of response to chemotherapy and of survival, allowing more accurate and earlier prediction than standard predictors. Entropy and homogeneity were the radiomic features with the strongest clinical impact. In the next few years, radiomics is expected to give a consistent contribution to the precision medicine approach to patients with liver metastases.
This report, or a modified version of it, has been also submitted to, or published on
Fiz, F., Viganò, L., Gennaro, N., Costa, G., La Bella, L., Boichuk, A., ... & Torzilli, G. (2020). Radiomics of liver metastases: a systematic review. Cancers, 12(10), 2881.